On the basis of positive results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT), Novartis Pharmaceuticals plans to file for a new indication for valsartan (Generic Diovan®). This is the only cardiovascular agent ever shown in a rigorous head-to-head trial to have all of the proven benefits of captopril (Capoten drug, Apothecon), an angiotensin-converting [...]
Clopidogrel bisulfate (Plavix, Bristol-Myers Squibb/Sanofi-Aventis) has been approved for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI) and who are not scheduled for angioplasty (coronary artery repair). A STEMI is a severe heart attack caused by the sudden, total blockage of an artery. The drug prevents subsequent [...]
An oral drug generic Avandia is related to the thiazolidinedione class of diabetes drugs. Made by GlaxoSmithKline this drug is used by around 1 million Americans in treating diabetes to control their blood sugar. It has been known that yesterday an advisory committee to the federal agency voted to keep the Rosiglitazone diabetes on the [...]
